Furthermore, danazol inhibits the production of IL-1 and TNF by monocytes in a dose-dependent manner (67) and inhibits the cytotoxicity of macrophage/monocyte-mediated susceptible target cells in patients with mild endometriosis (68). This evidence concerns the gene TNF and endometriosis.